Expect to see these generic versions hitting the Indian market around early 2027
It's about getting you back to your routine, or your sport, sooner and stronger
Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide [0.03-, 0.07-, and 0.5-fold the maximum recommended human dose (MRHD) of 15 mg once weekly based on AUC] during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
The Best Injection Sites for GHK-Cu Peptide Therapy Dr
These mechanisms work together, and the risk tends to be higher with higher doses and longer treatment time